ASSESSMENT OF THE EFFECT OF DRUG FORMULATION ON THE EXTENT OF THE PHARMACOKINETIC INTERACTION BETWEEN VORICONAZOLE AND TACROLIMUS

被引：0
|
作者：
Ott, Christian [2 ]
Huppertz, Andrea [2 ]
Foerster, Kathrin [2 ]
Burhenne, Juergen [2 ]
Weiss, Johanna [2 ]
Bruckner, Thomas [3 ]
Zorn, Markus [1 ]
Haefeli, Walter-Emil [2 ]
Czock, David [2 ]
机构：
[1] Univ Hosp Heidelberg, Cent Lab, Heidelberg, Germany
[2] Univ Hosp Heidelberg, Dept Clin Pharmacol & Pharmacoepidemiol, Heidelberg, Germany
[3] Univ Hosp Heidelberg, Dept Med Biometry, Heidelberg, Germany
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP740
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Voriconazole and fluconazole in kidney transplant recipient receiving tacrolimus: a case of drug interaction
    Salouage, I.
    Trabelsi, S.
    Charfi, R.
    Gaies, E.
    Jebabli, N.
    Lakhal, M.
    Klouz, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 87 - 88
  • [22] Pharmacokinetic interaction between tacrolimus and nicardipine: a case report
    Ben Sassi, M.
    Gaies, E.
    Salouage, I.
    Trabelsi, S.
    Charfi, R.
    Jebabli, N.
    El Jebari, H.
    Lakhal, M.
    Klouz, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 98 - 99
  • [23] The Drug Interactions between Tacrolimus and Fluconazole or Voriconazole in Heart Transplant Patients
    Methot, J.
    St-Pierre, Pelletier A. A.
    Picard, F.
    Chateauvert, N.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2022, 75 (02): : 145 - 145
  • [24] Whole Body Physiologically Based Pharmacokinetic Model to Explain A Patient With Drug-Drug Interaction Between Voriconazole and Flucloxacillin
    Abdullah-Koolmees, Heshu
    van den Nieuwendijk, Julia F.
    ten Hoope, Simone M. K.
    de Leeuw, David C.
    Franken, Linda G. W.
    Said, Medhat M.
    Seefat, Maarten R.
    Swart, Eleonora L.
    Hendrikse, N. Harry
    Bartelink, Imke H.
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2024, 49 (06) : 689 - 699
  • [25] Switching from intravenous to oral tacrolimus and voriconazole leads to a more pronounced drug–drug interaction
    Isabel Spriet
    Veerle Grootaert
    Geert Meyfroidt
    Yves Debaveye
    Ludo Willems
    European Journal of Clinical Pharmacology, 2013, 69 : 737 - 738
  • [26] Lack of Drug-Drug Interaction between Maribavir and Voriconazole
    Song, I. H.
    Ilic, K.
    Wu, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 779 - 779
  • [27] A model-based pharmacokinetic assessment of drug-drug interaction between tacrolimus and nirmatrelvir/ritonavir in a kidney transplant patient with COVID-19
    Tomida, Takeshi
    Itohara, Kotaro
    Yamamoto, Kazuhiro
    Kimura, Takeshi
    Fujita, Kohei
    Uda, Atsushi
    Kitahiro, Yumi
    Yokoyama, Naoki
    Hyodo, Yoji
    Omura, Tomohiro
    Yano, Ikuko
    DRUG METABOLISM AND PHARMACOKINETICS, 2023, 53
  • [28] Assessment of Pharmacokinetic Drug Interaction Between LCZ696 and Digoxin
    Ayalasomayajula, Surya
    Jordaan, Pierre
    Pal, Parasar
    Albrecht, Diego
    Langenickel, Thomas
    Sunkara, Gangadhar
    Chandra, Priyamvada
    HYPERTENSION, 2013, 62 (03)
  • [29] Assessment of Pharmacokinetic Drug Interaction between LCZ696 and Metformin
    Mendonza, Anisha
    Akahori, Mizuki
    Langenickel, Thomas
    Swan, Therese
    Pal, Parasar
    Sunkara, Gangadhar
    Chandra, Priyamvada
    HYPERTENSION, 2013, 62 (03)
  • [30] Pharmacokinetic and pharmacodynamic drug-drug interaction assessment between pradigastat and digoxin or warfarin
    Yan, Jing-He
    Meyers, Dan
    Lee, Zachary
    Danis, Kate
    Neelakantham, Srikanth
    Majumdar, Tapan
    Rebello, Sam
    Sunkara, Gangadhar
    Chen, Jin
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (07): : 800 - 808
12345